Medpace Holdings (MEDP) Change in Receivables (2015 - 2026)

Medpace Holdings (MEDP) has reported Change in Receivables for 12 consecutive years, with $47.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Receivables fell 40.96% year-over-year to $47.2 million; the trailing twelve-month figure through Jun 2026 stood at $63.6 million (down 17.43% YoY), and the FY2025 full-year result was $106.2 million, up 4837.51% from the prior year.
• Change in Receivables advanced to $47.2 million in Q2 2026 per MEDP's latest filing, from -$7.8 million in the prior quarter.
• Across five years, Change in Receivables topped out at $79.9 million in Q2 2025 and bottomed at -$19.1 million in Q1 2024.
• Historically, Change in Receivables has averaged $14.4 million across 5 years, with a median of $9.6 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Receivables surged 7103.12% in 2022, then tumbled 540.06% in 2024.
• Over 5 years, Change in Receivables stood at $4.5 million in 2022, then jumped by 100.09% to $9.0 million in 2023, then sank by 270.32% to -$15.3 million in 2024, then surged by 290.49% to $29.1 million in 2025, then soared by 62.16% to $47.2 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $47.2 million, -$7.8 million, and $29.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.